Enhanced Systems and Methods for Mental Health Diagnosis and Treatment

Publication ID: 24-11857322_0001_PTD
Published: November 07, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Systems and Methods for Mental Health Diagnosis and Treatment,” Published Technical Disclosure No. 24-11857322_0001_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857322_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,322.

Summary of the Inventive Concept

An advanced system for evaluating, diagnosing, and stratifying patients with mental health issues, providing accurate probability scores, confidence levels, and personalized treatment plans.

Background and Problem Solved

The original patent disclosed systems and methods for screening, diagnosing, and stratifying patients with neuropsychiatric diseases. However, these systems lacked the ability to provide accurate probability scores, confidence levels, and personalized treatment plans. The present inventive concept addresses these limitations by introducing enhanced systems and methods that improve the accuracy and effectiveness of mental health diagnosis and treatment.

Detailed Description of the Inventive Concept

The new inventive concept comprises systems and methods that integrate advanced machine learning algorithms, Bayesian Decision Lists, and cognitive task outcome measures to provide accurate probability scores and confidence levels for mental health conditions. The systems can output mental health conditions with a probability score of accuracy, recommend personalized treatment plans based on the patient's medical history, identify potential biomarkers, and track the progress of a patient's mental health condition in real-time. The methods involve receiving input features from patients, applying Bayesian Decision Lists, and outputting mental health conditions with confidence levels.

Novelty and Inventive Step

The new claims introduce the concept of probability scores, confidence levels, and personalized treatment plans, which are not present in the original patent. The use of Bayesian Decision Lists and cognitive task outcome measures to improve the accuracy of mental health diagnosis is also novel and non-obvious.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different machine learning algorithms, additional input features, or integration with wearable devices and electronic health records. Variations could include systems for diagnosing specific mental health conditions, such as bi-polar disorder or PTSD.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the mental health industry, with applications in healthcare providers, pharmaceutical companies, and research institutions. The market for mental health diagnosis and treatment is growing rapidly, and the present inventive concept is well-positioned to capture a significant share of this market.

Original Patent Information

Patent NumberUS 11,857,322
TitleSystems and methods for screening, diagnosing, and stratifying patients
Assignee(s)Neumora Therapeutics, Inc.